Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Journal of Clinical Oncology, 07/30/09
Sanson M et al. – The study indicates that IDH1 codon 132 mutation is closely linked to the genomic profile of the tumor and constitutes an important prognostic marker in grade 2 to 4 gliomas.
Related Articles
Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: A phase II study
Neurosurgery, 11/25/09
Relevance Score: 90%
Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1
Journal of Neuro-Oncology, 11/19/09
Relevance Score: 90%
Height, Body Mass Index, and Physical Activity in Relation to Glioma Risk
Cancer Research, 11/02/09
Relevance Score: 90%
Diagnostic and prognostic markers in gliomas
Current Opinion in Oncology, 10/13/09
Relevance Score: 90%
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches
Current Opinion in Neurology, 11/11/09
Relevance Score: 89%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of p16 in benign and malignant cystic squamous lesions of the neck
Human Pathology, 12/19/09
Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas
Human Pathology, 12/19/09
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/19/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Journal of Neuro-Oncology, 12/17/09
Secretory meningiomas: A benign subgroup causing life-threatening complications
Neuro-Oncology, 12/17/09
Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array
Neuro-Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


